Clinical Trial Update: Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

This is an update on an ongoing Phase 2 clinical trial evaluating maintenance combinatorial myeloid immunotherapy for unresectable pancreatic ductal adenocarcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University of Pennsylvania | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: RECRUITING